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Abstract
Patients with fear of blushing as the predominant complaint (N= 31) were randomly
assigned to (1) exposure in vivo (EXP), or (2) task concentration training (TCT), in order
to test the effect of redirecting attention above exposure only. In addition, it was
investigated whether treatment reduced actual blush behavior; therefore, physiological
parameters of blushing were measured during two behavioral tests. Half of the patients
served as waiting-list controls first. Assessments were held before and after treatment, at 6-
weeks, and at 1-year follow-up. Both treatments appeared to be effective in reducing fear
of blushing and realizing cognitive change. Yet, at posttest, TCT tended to produce better
results with respect to fear of blushing. At 6-weeks follow-up, TCT produced significantly
more cognitive change. At 1-year follow-up, patients further improved, while differential
effects had disappeared. The reduction in fear of blushing was not paralleled by a reduction
in actual blush behavior during the behavioral assessments. Thus, it seems that fear of
blushing reflects a fearful preoccupation, irrespective of actual facial coloration. D 2001
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1. Introduction
Individuals with social phobia almost always experience symptoms of
anxiety in social situations (e.g., blushing, palpitations, tremors, sweating,
etc.) (American Psychiatric Association, 1994). In various cases, anxiety
seems to be centered around the showing of physical symptoms (like blushing),
turning the occurrence of these bodily reactions into the source of fear; in many
social phobics, fear of blushing appears to be a prominent complaint, indeed
(Edelmann, 1990).
In the last 15 years, several controlled treatment outcome studies have been
conducted on social phobia, including individual as well as group treatment, and
comparisons between purely behavioral, purely cognitive, and combined cognit-
ive–behavioral treatment methods (e.g., Butler, Cullington, Munby, Amies, &
Gelder, 1984; Emmelkamp, Mersch, Vissia, & Van der Helm, 1985; Gelernter et
al., 1991; Heimberg et al., 1990; Hope, Heimberg, & Bruch, 1995; Mattick &
Peters, 1988; Mattick, Peters, & Clarke, 1989; Scholing & Emmelkamp, 1993b).
The results of these studies generally show that, although social phobia has been
linked to cognitive distortions, behavioral and cognitive treatments are equally
effective (Feske & Chambless, 1995).
Yet, it remains largely unclear whether results of these studies can also
be applied to social phobia with fear of blushing as the predominant
complaint. Thus far, only two controlled treatment outcome studies have
investigated the effects of cognitive–behavioral treatments for social phobics
with fear of bodily symptoms as the central complaint. One study compared
exposure followed by cognitive therapy, cognitive therapy followed by
exposure, and a package in which both methods were integrated from the
start (Scholing & Emmelkamp, 1993a), whereas the other study compared
cognitive therapy to applied social skills training (Bögels, 1994). All
treatment methods that were used in these studies proved equally effective.
However, in both studies, effect sizes were rather modest, supporting the
clinical impression that social phobics with fear of bodily symptoms are
relatively difficult to treat.
One way to enhance treatment efficacy in blushing phobics may be to
specifically address detrimental attentional processes. That is, social phobics
tend to focus attention excessively on themselves in social situations [‘height-
ened self-focused attention (SFA)’] (e.g., Clark & Wells, 1995; Daly, Vangelisti,
& Lawrence, 1989; Hope, Gansler, & Heimberg, 1989; Wells & Matthews,
1994). As a result, feelings of anxiety, (awareness of) physical symptoms, and
awareness of negative ideas about the self might be caused. Furthermore, less
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attention might be available to be directed at the task at hand, which is likely to
result in poor social performance (Bögels, Mulkens, & de Jong, 1997; Clark &
Wells, 1995).
It is important to note that the experience of social attention might be
especially detrimental to people with fear of blushing. It is known that undesired
social attention and concern over appearance are elicitors of blushing (cf. Leary,
Britt, Cutlip, & Templeton, 1992), whereas the experience of blushing is likely to
intensify public self-consciousness (e.g., Wegner & Giuliano, 1980). Thus,
blushing phobics seem to be captured in a vicious circle. Given the possibly
detrimental effects of enhanced SFA, teaching blushing phobics to focus attention
on the pertinent aspects of the situation (the ‘task’), instead of focusing inward on
feelings, thoughts, and symptoms, might well be helpful in treating anxiety
(Bögels et al., 1997).
Therefore, we developed an attention training for fear of blushing, task
concentration training (TCT). TCT consists of three phases: (1) getting insight
into attentional processes and the effects of focusing attention on the self, (2)
focusing attention outward in nonthreatening situations, and (3) focusing
attention outward in threatening situations. Thus, attention training aims to
make patients aware of what is really going on around them and, as a
consequence, to reevaluate their thoughts about the feared situations. Moreover,
as SFA appears incompatible with task focus, attending to the (social) task may
be considered as an active coping technique. Several exploratory case studies
(Bögels et al., 1997; Mulkens, Bögels, & de Jong, 1999) have revealed
promising results.
The aim of the present study was to investigate the effectiveness of TCT
compared to exposure in vivo (EXP): an existing treatment of which the effects
on social phobia are well-established (e.g., Taylor, 1996). Another reason for
choosing EXP as a comparison treatment is the shared component in both
treatments of the hierarchical practicing of social situations. Therefore, such a
comparison allows us to evaluate whether adding attention training enhances the
efficacy of exposure only.
We investigated the effects of TCT and EXP on self-report measures of
erythrophobia, as well as on actual blushing behavior. Furthermore, TCT
was expected to specifically influence blushing phobics’ negative cognitions,
by providing the opportunity to experience disconfirming information (cf.
Bögels et al., 1997; Clark & Wells, 1995). To investigate the relative
efficacy of TCT, erythrophobics were treated individually with either EXP or
TCT. Half of the subjects served as a waiting-list control group, waiting 6
weeks before receiving treatment. Before and after treatment (or waiting
list), we assessed patients’ fear of blushing and negative cognitions, and
carried out a behavioral test, during which actual blushing (i.e., blood
pooling in the cheek) and self-reported blushing intensity were recorded.
Inclusion of both objective (i.e., physiology) and subjective indices of
blushing allows to differentiate between fearful preoccupation and actual
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facial coloration (cf. Mulkens, de Jong, & Bögels, 1997; Mulkens, de Jong,
Dobbelaar, & Bögels, 1999).
2. Method
2.1. Patients
Patients were included in the study when they met the following criteria: a
primary diagnosis of social phobia (DSM-IV), with fear of blushing in social
situations as the prominent fear, no (cognitive–) behavioral treatment for
erythrophobia in the past 2 years, no use of medication for fear of blushing.
Patients were recruited by means of advertisements, in which people who
suffered from fear of blushing were offered treatment.
Patients were first screened over the telephone, after which 40 individuals
were invited for an intake session. They were interviewed by means of a
structured clinical interview for DSM-III-R disorders (the SCID; Spitzer &
Williams, 1986). Furthermore, they were asked to fill out the subscale ‘fear of
blushing’ of the Blushing, Trembling, and Sweating Questionnaire (BTS-Q;
Bögels & Reith, 1999) on which they had to score above a certain cut-off point:
at least 1.5 S.D.s higher than the mean score obtained by students (Bögels,
Alberts, & de Jong, 1996), implying that men had to score at least 38.6 and
women 51.2 (range 0–100).
Nine of the 40 individuals undergoing the intake did not enter treatment: four
appeared to be not rightly classified, four did not accept treatment because of
practical reasons, and one did not show up anymore. All remaining 31 patients
(seven men) had a primary diagnosis of social phobia, with fear of blushing as the
predominant complaint. At intake, mean ‘fear of blushing’ scores were 65.7 (S.D.
12.8) and 77.0 (S.D. 14.5) for women and men, respectively.
2.2. Experimental design and procedure
All patients were screened by the first author, and SCID interviews were
conducted by a trained psychologist. After the intake session, the first assessment
took place (Pretest I), after which half of the patients started immediately with the
treatment, being randomly assigned to EXP or TCT. The other half started
treatment after a 6-week waiting-list period, at the end of which a second
assessment took place (Pretest II). Then, these latter patients were also randomly
assigned to one of the two treatments. Of the 31 patients who started treatment, 5
patients dropped out (16%): 3 from TCT, 2 from EXP. Eventually, 12 patients
finished the EXP treatment, and 14 finished the TCT treatment. Patients were
assessed on behavioral tests, on questionnaires, and on diary recordings at Pretest
I, Pretest II, and Posttest. After a 6-week follow-up period (FU I), and after 1 year
(FU II), they completed the questionnaires again.
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2.3. Treatment
2.3.1. Therapists
Five female students, who had almost finished their studies in Mental Health
Sciences at Maastricht University and had passed a clinical training, functioned
as therapists. They received an intensive 3-day training in the treatment
procedures, provided by the first and second authors. All therapists attended
weekly supervision sessions.
2.3.2. General aspects
Both treatments consisted of six weekly 1-h sessions. Both treatments
followed an identical structure: in Session 1 the rationale was explained, in
Session 2 general exercises were done, in Session 3 a hierarchy of fearful
situations was constructed, and in the following three sessions the items from the
hierarchy were practiced within and between sessions, by means of role plays and
in vivo exercises. Both rationales emphasized that the aim of treatment was to
become less afraid of blushing, and not to eliminate blushing. Patients were
instructed to practice extensively between sessions (at least 5 out of 7 days),
using homework diaries. Both treatments were kept pure; that is, no skills training
or cognitive restructuring took place.
2.3.3. Exposure in vivo
The EXP treatment was based on the latest insights into active exposure
components, that is, refraining from subtle avoidance strategies (like averting
the eyes or the body when blushing, wearing make-up) and dropping safety
behaviors (Wells et al., 1995). It was explained that by prolonged, graded,
and frequent exposure to feared situations, without applying (subtle) avoid-
ance strategies, the fear of blushing would eventually diminish. Standardized
unusual exposure exercises were done in Session 2, built up hierarchically:
from sitting silently for 2 min without having eye contact (sitting back-to-
back), to eventually sitting face-to-face, having eye contact without saying
anything for 2 min. Patients rated their anxiety (range = 0–100) before and
at the end, and their highest fear during the exercise. These exercises were
repeated, until fear decreased substantially. Homework assignments between
Sessions 2 and 3–4 were to make diary registrations of situations in which
patients had fear of blushing (i.e., kind of situation, whether they had
encountered or avoided it, whether they blushed, how they felt and with
which intensity, and what the consequence of avoidance had been), and to
do unusual things that had nothing to do with fear of blushing, like
wearing two different socks, or reading a ‘wrong’ magazine in the presence
of other people. This was to demonstrate that behaving differently causes
tension, but habituates. In the third session, an individual fear hierarchy was
constructed, which was practiced between and within sessions throughout
the remaining treatment.
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2.3.4. Task concentration training
In the rationale of TCT, the role of SFA in the maintenance of fear of blushing
was emphasized. The effects of SFA were demonstrated by an exercise: patients
were asked to tell the therapist a short story about their latest holidays, thereby
focusing all attention on the self: on thoughts, feelings, the way they thought they
came across to the therapist, etc. Then, the detrimental effects of SFA were
discussed, and connected to their daily social difficulties (Bögels et al., 1997).
The aim of the treatment would be to learn to direct more attention to the task at
hand instead of focusing on the self, so that the vicious circle of SFA and fear of
blushing would be broken and fear of blushing would decrease. In the second
session, concentration exercises were done in order to demonstrate the beneficial
effects of task-focused attention. These were listening exercises, built up
hierarchically (see Bögels et al., 1997 for details). Homework assignments
between Sessions 2 and 3–4 were to make diary registrations of the direction
of attention in blushing-fearful situations, and to do general, nonthreatening
concentration exercises. For example, walking through a quiet forest and
focusing attention alternately on the different sensorial aspects of the envir-
onment, watching the news very concentratedly and summarizing it afterwards,
etc. In the third session, an individual fear hierarchy was constructed, which was
practiced between and within sessions throughout the remaining treatment. The
aim was to practice directing attention to the task in these situations.
2.4. Assessment
2.4.1. Questionnaires
The following questionnaires were completed:
2.4.1.1. The Social Phobia and Anxiety Inventory (SPAI; Turner, Beidel, Dancu,
& Stanley, 1989; Dutch translation: Scholing, Bögels, & van Velzen,
1995). The social phobia subscale, which measures aspects of generalized
social phobia, was used for descriptive purposes. Patients rated each item on a
seven-point scale, rescaled from 0 (never) to 6 (always) (range 0–192). The
internal consistency is very high (.99; Bögels & Reith, 1999).
2.4.1.2. The Blushing Propensity Scale (BPS; Leary & Meadows, 1991; Dutch
version: Bögels et al., 1996). The Dutch BPS consists of 19 circumscribed
social situations for each of which the subject has to indicate how often she feels
herself blushing. Answers range from 0 (I never feel myself blushing in that
situation) to 4 (I always feel myself blushing in that situation). The internal
consistency of the Dutch BPS is high (.92; Bögels et al., 1996), as is its test–
retest reliability (.93; Mulkens et al., 1997).
2.4.1.3. The Blushing, Trembling, and Sweating Questionnaire (BTS-Q; Bögels &
Reith, 1999). In this study, we only used the part concerning blushing. The
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subscale ‘fear of blushing’ measures, by visual analog scales (VASs), to what
degree patients are afraid to blush and experience blushing as a problem
(range = 0–100). The subscale ‘bodily reactions while blushing’ indicates to what
extent certain bodily reactions are experienced during blushing (range = 0–4). The
subscale ‘blushing consequences’ indicates to what extent the patient, when
blushing, is hindered by disturbances in mental processes, such as blackouts or
problems in concentrating (range = 0–4). The subscale ‘blushing cognitions’
consists of positive and negative cognitions about blushing and its social
consequences, which are given a proportional score of 0% (‘I do not believe it
at all’) to 100% (‘I’m totally convinced’) (range = 0–100). The subscale ‘avoid-
ance of blushing’ measures the extent to which strategies are used to avoid or hide
blushing (range = 0–4). The last subscale of the BTS-Q asks the patient to estimate
how many times he or she blushed in the past week. The homogeneity of the BTS-
Q is satisfactory for all subscales (ranging from 0.77 to 0.98). Furthermore, the
BTS-Q has good discriminant validity; it is able to discriminate not only social
phobics from controls, but also social phobics with fear of bodily symptoms like
blushing from social phobics without such fears (Bögels & Reith, 1999).
2.4.1.4. The SFA scale (Bögels et al., 1996). This is a newly developed scale to
measure the focus of self-attention. It consists of 11 items: 6 items refer to self-
attention focused on one’s arousal (SFA-arousal) (range = 0–24), and 5 items
concern self-attention directed to one’s interpersonal behavior (SFA-perform-
ance) (range = 0–20). The internal consistency is high for both subscales (.86 and
.78, respectively; Bögels et al., 1996).
2.4.2. Idiosyncratic dysfunctional beliefs
Four main idiosyncratic dysfunctional beliefs (causal catastrophic misinter-
pretations, CCMs) of each patient with regard to their blushing were assessed
during the intake. An example of a CCM is: ‘When I blush, I look stupid’. Before
and after each treatment session, patients rated the beliefs on VASs (range 0–100).
2.4.3. Diary measures
Patients were instructed to record their blushing, anxiety, and associated
behavior systematically on self-monitoring diaries in the week prior to the start
of the treatment or waiting period and in the last week of the treatment or waiting
period. Everyday, patients answered questions concerning the extent to which
they had had fear of blushing (range 0–4), the intensity of this fear [ranging from
0 (not at all) to 100 (very much)], the extent to which they had conducted (subtle)
avoidance behavior and safety strategies (range 0–4), and which strategies they
used to become less anxious (0–4).
2.4.4. Behavioral and physiological assessment
The behavioral assessment consisted of a conversation with two stooges
(interaction test), and a short speech before an audience of four people
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(performance test), taken in a fixed order, during which physiological responses
were recorded. To measure changes in blood flow in the cheek, a photo-
plethysmograph probe was attached to the left cheek and a temperature probe to
the right cheek of the subject. Skin conductance electrodes were placed on the
medial phalanges of the middle finger and ring finger of subjects’ nondominant
hand. Cheek coloration was recorded from an HP model 15230A plethysmo-
graph transducer that was modified in such a way that it was DC-coupled rather
than AC-coupled. The probe operates in the infrared spectrum. Cheek temper-
ature was assessed by means of a temperature-dependent resistor (PT100) that
was DC-coupled. Skin conductance level was recorded from two Beckman
Ag–AgCl electrodes (8 mm diameter), placed on the medial phalanges of the
middle finger and ring finger of the subject’s nondominant hand, using the
method of constant voltage (0.5V). The electrodes were filled with an isotonic
paste and connected to a Beckman Skin Conductance Coupler (type 9844). All
physiological signals were sampled with a frequency of 1000 Hz by a Compaq
486 (33 MHz) computer.
When all equipment had been attached, the research assistant left the room and
asked the patient to sit and relax for a short while (2.5 min), during which a
baseline recording was made. After that, the patient filled out a short self-report,
consisting of two VASs (‘How anxious were you in the past 2.5 minutes?’ and
‘How much did you blush during the past 2.5 minutes?’).
Then, patients were informed that they were expected to have a conversation
with two people (a man and a woman) during 5 min (cf. Öst, Jerremalm, &
Johansson, 1981) and that these two stooges would make notes to judge their
interaction behavior. After the conversation, patients filled out the self-report
again. Physiological responses were recorded during another period of 2.5 min, in
order to measure physiological recovery from the conversation.
After a 20-min break (recovery period), patients did the second test. After a
2.5-min baseline measurement and the completion of the two self-report VASs,
the test was explained. The patient was told to give a 3-min speech in front of an
audience of four people, after 2 min preparation time. The subject of the speech
could be freely chosen. The audience would judge the patient’s skills. After the
test, the patient completed the self-report, whereas the physiology was recorded
for an additional 2.5 min (recovery).
2.5. Treatment credibility and integrity
Treatment credibility was firstly assessed after the rationale was explained.
Patients filled out a three-item questionnaire: (1) how logical does this form of
treatment seem to be for you?; (2) how confident are you that this treatment will
help you overcome your fear of blushing?; and (3) to what extent would you
advise this treatment to a friend with similar problems? On a scale, from 1 (not at
all ) to 9 (extremely). Treatment credibility was again assessed at posttest, at FU I,
and at FU II.
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Treatment integrity was assessed by audiotaping all treatment sessions. The
first author listened to 10-min segments of tapes chosen at random and compared
the content to the treatment manual. Feedback about the audiotaped sessions was
given during supervision, in order to maximize the purity of the treatments. To
determine whether the training had led to the predicted strategic behavior,
patients indicated in diaries (see diary measures) what strategies they used to
become less anxious: relaxation, thinking less catastrophically, concentrating on
the task at hand (i.e., TCT), or staying in the situation until the anxiety
diminished (i.e., EXP).
2.6. Data reduction
In this study, two broad questions were addressed, each divided into more
specific questions: (1) what is the effect of treatment vs. waiting list on (a) fear of
blushing and cognitive change, and (b) actual blushing and self-reported blushing
and anxiety during behavioral tests; and (2) are there differential treatment effects
of TCT vs. EXP on (a) fear of blushing and cognitive change, and (b) actual
blushing and self-reported blushing and anxiety during behavioral tests? Both (a)
questions will be addressed by using the self-report questionnaires and the
CCMs, whereas physiological variables and self-reports of the behavioral tests
will serve to address the (b) questions.
To minimalize the risk of Type I errors, dependent variables were divided into
two groups: outcome and descriptive variables. Only the first set of variables was
used to test the hypotheses. To measure changes in ‘fear of blushing’, we used
two outcome variables: the BTS-Q subscale ‘fear of blushing’ and a newly
composed measure, built up from the Blushing Propensity Scale (BPS) and the
BTS-Q subscales ‘bodily reactions while blushing’, ‘blushing consequences’, and
‘avoidance of blushing’. This composite variable is called ‘blushing responsive-
ness and consequences’. To measure cognitive change, the BTS-Q subscale
‘negative cognitions’ and the CCMs were used. To this end, mean CCM scores at
the start and at the end of waiting and treatment, respectively, were computed.
The other variables (diaries,1 SPAI, SFA-arousal, SFA-performance, BTS-Q-
blushing frequency, and BTS-Q-positive cognitions) were used for descriptive
purposes only.
With regard to the (b) questions (effects on actual blushing), we used the
cheek coloration data from the behavioral tests. These data were analyzed as
follows: every 30 s the level was selected, resulting in 10 values during the
conversation, and 6 values during the presentation. Mean values were calculated
for each period. We also collected cheek temperature and skin conductance data.
1 The descriptive diary data were reduced by calculating a composite measure, constructed of two
correlated (r = 0.50, P= .005) variables: ‘Fear of blushing’ (the item ‘the extent of fear of blushing’
multiplied by ‘the intensity of this fear’, resulting in a range of 0–400) and ‘avoidance’ (built up out
of diary items that all measured aspects of avoidance (range 0–4)).
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However, the results obtained were highly similar and thus only the results for the
cheek coloration data are presented, whereas the results of cheek temperature and
skin conductance level are presented in a footnote.
To investigate changes in self-reported blushing and anxiety, self-report data
during the behavioral tests were used. Because these data violated the assumption
of normality, transformations were performed, using the following formula:
nvar = ln((var + 1)/(101 var)).
2.7. Statistical analyses
Of the 31 subjects who originally started treatment, 4 (in the ‘treatment-at-
once’ condition) were eliminated from the final data analysis due to a failure to
complete treatment. One subject (in the ‘waiting-list’ condition) completed
most of the waiting-list measurements (that is, CCMs were available, and the
data of the behavioral assessment) but dropped out during treatment. This case
was included in the analyses of the ‘waiting-list’ vs. ‘treatment-at-once’ effects.
Two patients (both waiting-list controls) refused to do one or more behavioral
tests because they felt too anxious to carry them out. At FU II, 21 patients
returned their questionnaires: 9 in the EXP condition, and 12 in the TCT
condition. Only patients who completed both posttest and FU II assessments,
were included in the comparison analyses of pretest vs. 1-year follow-up, and
posttest vs. 1-year follow-up.
Waiting-list effects vs. treatment effects and differential treatment effects were
tested with multivariate analyses of variance (MANOVAs) with one between-
groups factor (Group: waiting vs. treatment, or Condition: EXP vs. TCT), using
difference scores between relevant time assessments.
To determine clinically significant change, the number of patients who
improved significantly in both treatments were compared by means of a chi-
square. When norms of a functional population are available, Jacobson and
Truax (1991) advise using the point that lies halfway between the mean of
the functional and dysfunctional population. Cutoff scores of 45.7 and 43.5
were established for men and women, respectively [using the means of the
present dysfunctional population, and a functional population from Bögels &
Reith, 1999 (i.e., 14.5 for men, and 21.3 for women)]. Effect sizes of changes
in fear of blushing were computed as an indication of treatment effects
(Cohen, 1988).
3. Results
3.1. Dropouts versus completers
Five patients dropped out during treatment, because of lack of confidence in
the treatment, time constraints, improvement, fear, or a combination of these
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reasons. A striking demographic feature was the difference between dropouts and
completers in the mean duration of their complaint, being only 4.6 (S.D. 3.1)
years for dropouts, and 13.5 (S.D. 10.1) years for completers. Shorter duration
might imply less distress and, therefore, sooner dropping out. Still, dropouts had
higher initial ‘fear of blushing’ scores (75.1; S.D. 15.6) than completers (62.1;
S.D. 16.3).
3.2. Waiting list versus treatment at once
Results regarding outcome are summarized in Tables 1 and 2.
3.2.1. (1a) Effects on fear of blushing
The MANOVA revealed a significant effect of treatment above waiting
list, [F hot(2,23) = 4.5, P < .05]. Univariate F tests showed that this effect
was mainly due to the variable ‘blushing responsiveness and consequen-
ces’ [F(1,24) = 9.4, P= .005], and to a lesser extent to the variable BTS-
Q ‘fear of blushing’ [F(1,24) = 3.7, P= .07]. Thus, it can be concluded
that a 6-week treatment produces better results than waiting list (see also
Table 1).
3.2.2. (1a) Effects on negative cognitions
The MANOVA yielded no significant effect of treatment above waiting list
[F hot(2,23) = 1.7]. However, there was an overall significant decrease in
negative cognitions [F hot(2,24) = 11.5, P < .001] (see also Table 1).
Table 1
Effects of waiting (WL) versus treatment (NWL) on outcome measures (mean and S.D.)
Variable Pretest I Pretest II/ Posttest
BTS-Q — fear of blushing
WL (n= 14) 63.11 (19.18) 56.44 (20.18)
NWL (n= 12) 60.74 (12.78) 42.64 (20.28)
Blushing responsiveness and consequences
WL (n= 14) 2.24 (0.41) 2.22 (0.40)
NWL (n= 12) 1.96 (0.42) 1.56 (0.55)
BTS-Q — Negative cognitions
WL (n= 14) 58.00 (9.81) 50.87 (9.98)
NWL (n= 12) 48.63 (20.47) 35.21 (21.69)
CCMs
WL (n= 15) 83.55 (9.75) 73.07 (12.86)
NWL (n= 12) 75.08 (13.40) 49.25 (25.07)
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3.2.3. (1b) Effects on actual blushing
Plethysmograph values at different occasions are summarized in Table 2. The
MANOVA revealed no significant difference between treatment and waiting
[F hot(2,20) = 0.23].2 Furthermore, there was no significant overall decrease in
actual blushing [F hot(2,21) = 1.8, P > .1].
3.2.4. (1b) Effects on self-reported blushing and anxiety
In Table 2, values of self-reported blushing and anxiety on different occasions
are presented. The MANOVAwith regard to self-reported blushing did not reveal
a difference between treated patients and waiting-list patients [F hot(2,23) = 0.15],
nor did the MANOVA with regard to self-reported anxiety [F hot(2,23) = 0.07].
Yet, for both variables, there appeared to be an overall significant decrease at the
second behavioral test [F hot(2,25) = 11.1, P < .001 and F hot(2,25) = 15.9,
P < .001, respectively].
Table 2
Effects of waiting (WL) versus treatment (NWL) on three physiological measures, self-reports of
blushing, and self-reports of anxiety during conversation, and presentation (mean and S.D.)
Variables Pretest I Pretest II/Posttest
Conversation
Cheek coloration (V) WL (n= 14) 4.25 (2.29) 3.32 (1.98)
NWL (n= 9) 3.06 (1.75) 1.22 (2.80)
Cheek temperature (C) WL (n= 14) 3.23 (0.20) 3.20 (0.14)
NWL (n= 9) 3.14 (0.15) 3.18 (0.19)
SCLa (mmho) WL (n= 12) 1.88 (0.26) 1.64 (0.67)
NWL (n= 10) 1.58 (0.47) 1.72 (0.66)
Self-reported blushing (transformed)b WL (n= 14) 0.42 (1.19)  0.64 (1.58)
NWL (n= 12)  1.05 (1.93)  2.23 (1.62)
Self-reported anxiety (transformed)b WL (n= 14) 0.45 (1.67)  0.57 (1.94)
NWL (n= 12)  0.33 (1.32)  1.48 (1.61)
Presentation
Cheek coloration (V) WL (n= 14) 3.10 (2.46) 2.70 (1.70)
NWL (n= 9) 2.87 (2.26) 2.00 (1.68)
Cheek temperature (C) WL (n= 14) 3.24 (0.18) 3.24 (0.17)
NWL (n= 9) 3.21 (0.19) 3.21 (0.19)
SCLa (mmho) WL (n= 12) 1.77 (0.29) 1.60 (0.73)
NWL (n= 10) 1.54 (0.32) 1.56 (0.61)
Self-reported blushing (transformed)b WL (n= 14)  0.47 (1.62)  0.92 (1.57)
NWL (n= 12)  0.59 (2.12)  1.37 (1.94)
Self-reported anxiety (transformed)b WL (n= 14) 0.68 (1.31)  0.27 (1.66)
NWL (n= 12) 0.36 (0.84)  0.48 (1.20)
a SCL values are SQRT transformed.
b Self-reports are transformed using this formula: nvar = ln((var + 1)/(101 var)).
2 The MANOVAs with regard to cheek temperature and skin conductance level revealed no
significant main effect of group [ F(2,20) = 0.77, and F(2,19) = 1.87, P= .18, respectively].
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3.3. Differential treatment effects
Results on outcome and descriptive variables are summarized in Tables 3,
4, and 5.
3.3.1. Credibility of treatment rationale and treatment integrity
There was no difference between the two treatments concerning credibility of
the treatment rationale on any given moment: pretest [t(24) = 0.5 (means being
6.43 (S.D. 1.29) for EXP and 6.64 (S.D. 0.95) for TCT], posttest [t(24) = 0.3
(means 6.42 (S.D. 1.38) and 6.64 (S.D. 1.95) for EXP and TCT, respectively], FU
I [t(24) = 0.4 (means 6.64 (S.D. 1.43) and 6.38 (S.D. 1.90) for EXP and TCT,
respectively], and FU II [t(19) = 0.5 (means 6.30 (S.D. 1.58) and 6.25 (S.D. 2.26)
for EXP and TCT, respectively].
Inspection of the patients’ diaries revealed that EXP patients indicated that
they did not practice any of the strategies more frequently after treatment. Patients
in the TCT group, however, practiced ‘concentrating on the task at hand’
significantly more often after treatment [t(13) = 4.2, P < .001 (means being 1.3
and 2.4 before and after treatment, respectively], whereas there were no differ-
ences with respect to the other strategies.
3.3.2. (2a) Effects on fear of blushing
There was a borderline significant treatment effect of TCT above EXP at
posttest [F hot(2,23) = 3.2, P= .06]. At FU I, this effect had disappeared
[F hot(2,23) = 0.2]. When pretest was compared to FU II, no differential
effects were present either [F hot(2,18) = 0.2]. A comparison of posttest with
Table 3
Effects of EXP versus TCT on outcome measures (mean and S.D.) on four test occasions
Variable Pretest Posttest FU I FU IIa
BTS-Q — fear of blushing
EXP (n= 12) 51.26 (16.49) 42.82 (20.72) 30.60 (18.73) 28.17 (19.49)
TCT (n= 14) 64.56 (15.37) 45.79 (21.20) 40.18 (20.50) 34.17 (24.48)
Blushing responsiveness and consequences
EXP (n= 12) 2.16 (0.39) 1.74 (0.57) 1.71 (0.63) 1.73 (0.26)
TCT (n= 14) 2.05 (0.46) 1.74 (0.64) 1.60 (0.55) 1.51 (0.65)
BTS-Q — negative cognitions
EXP (n= 12) 43.25 (15.32) 33.69 (18.23) 33.67 (18.78) 31.41 (16.94)
TCT (n= 14) 55.48 (13.54) 36.95 (20.35) 32.30 (19.19) 26.67 (17.78)
CCMs
EXP (n= 12) 73.77 (8.99) 48.46 (20.39) 38.83 (25.79) 48.00 (28.56)
TCT (n= 14) 73.61 (16.11) 49.09 (28.05) 39.21 (24.82) 36.15 (24.99)
a n= 9 (EXP)/n= 12 (TCT) at FU II.
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FU II indicates that treated patients in both conditions improved further
[F hot(2,19) = 6.8, P < .01] (see also Table 3).
3.3.3. (2a) Effects on cognitions
A MANOVAyielded no significant difference with regard to cognitive change
between the two treatments at posttest [F hot(2,23) = 1.9, P > .1]. However, at FU
I, there was a significant difference in favor of TCT [F hot(2,23) = 4.2, P < .05].
This effect was mainly due to the variable ‘BTS-Q negative cognitions’
[F(1,24) = 5.0, P < .05], compared to the variable ‘CCMs’ [F(1,24) = .07, n.s.].
Table 4
Effects of EXP versus TCT on three physiological measures, self-reports of blushing, and self-reports
of anxiety during conversation, and presentation (mean and S.D.)
Variables Pretest Posttest
Conversation
Cheek coloration (V) EXP (n= 8) 2.70 (1.45) 1.32 (3.46)
TCT (n= 11) 2.74 (1.56) 2.52 (1.40)
Cheek temperature (C) EXP (n= 9) 3.17 (0.13) 3.15 (0.15)
TCT (n= 11) 3.15 (0.16) 3.17 (0.18)
SCLa (mmho) EXP (n= 10) 1.60 (0.40) 1.61 (0.62)
TCT (n= 10) 1.53 (0.72) 1.39 (0.66)
Self-reported blushing (transformed)b EXP (n= 12)  0.61 (1.46)  1.28 (1.61)
TCT (n= 12)  1.08 (2.01)  2.07 (1.65)
Self-reported anxiety (transformed)b EXP (n= 12)  0.68 (1.86)  0.85 (1.74)
TCT (n= 12)  0.44 (1.59)  1.97 (1.63)
Presentation
Cheek coloration (V) EXP (n= 8) 2.87 (2.26) 1.98 (0.63)
TCT (n= 11) 2.34 (1.80) 2.10 (1.56)
Cheek temperature (C) EXP (n= 9) 3.19 (0.13) 3.18 (0.14)
TCT (n= 11) 3.22 (0.20) 3.21 (0.18)
SCLa (mmho) EXP (n= 10) 1.50 (0.51) 1.35 (0.68)
TCT (n= 10) 1.52 (0.57) 1.32 (0.62)
Self-reported blushing (transformed)b EXP (n= 12)  0.96 (1.50)  0.93 (1.33)
TCT (n= 12)  0.69 (1.88)  1.60 (2.04)
Self-reported anxiety (transformed)b EXP (n= 12)  0.28 (1.64)  0.55 (1.70)
TCT (n= 12) 0.20 (1.14)  0.36 (1.26)
a SCL values are SQRT transformed.
b Self-reports are transformed using this formula: nvar = ln((var + 1)/(101 var)).
Table 5
Percentage of patients showing clinically significant change and effect sizes of both treatment
conditions at posttest, FU I, and FU II
Percentage of clinically significant change (%) Effect size
Fear of blushing Posttest FU I FU II Posttest FU I FU II
TCT 43 50 58 1.14 1.40 1.48
EXP 42 75 89 0.51 1.19 1.20
S. Mulkens et al. / Anxiety Disorders 15 (2001) 413–432426
At FU II, this differential effect was gone [F hot(2,18) = 1.8, P > .1]. A compar-
ison between posttest and FU II yielded a tendency for an overall further
improvement [F hot(2,19) = 3.2, P= .06] (see also Table 3).
3.3.4. (2b) Effects on actual blushing
Plethysmograph values at different occasions are summarized in Table 4. The
MANOVA revealed no difference between TCT and EXP [F hot(2,17) = 0.6].3
3.3.5. (2b) Effects on self-reported blushing and anxiety
In Table 4, self-reported blushing and anxiety on different occasions are
presented. The MANOVA revealed no significant difference between TCT
and EXP on self-reported blushing [F hot(2,21) = 1.8], nor on anxiety
[F hot(2,21) = 2.1, P > .1].
Table 6
Descriptive statistics on descriptive variables of questionnaires (mean and S.D.) of patients who
completed treatment in the EXP vs. TCT condition
Variable Pretest Posttest FU I FU IIa
SPAI-social phobia
EXP (n= 12) 76.49 (25.30) 70.27 (28.15) 65.36 (27.72) 66.36 (23.45)
TCT (n= 14) 92.00 (24.61) 83.10 (30.61) 75.25 (27.08) 70.76 (30.33)
SFA-arousal
EXP (n= 12) 7.58 (5.99) 4.58 (4.68) 6.42 (5.09) 3.56 (3.40)
TCT (n= 14) 8.71 (4.89) 8.21 (6.64) 7.07 (5.92) 3.75 (3.08)
SFA-performance
EXP (n= 12) 8.92 (4.60) 6.75 (5.10) 7.50 (4.95) 8.56 (6.04)
TCT (n= 14) 9.64 (4.45) 8.71 (5.47) 9.21 (4.49) 6.75 (5.05)
Diary — composite fear and avoidanceb
EXP (n= 11) 0.53 (0.38) 0.36 (0.26) No follow-up No follow-up
TCT (n= 14) 0.75 (0.35) 0.44 (0.27)
BTS-Q — positive cognitions
EXP (n= 12) 34.25 (14.55) 34.42 (14.03) 35.58 (20.41) 44.83 (21.72)
TCT (n= 14) 27.21 (18.54) 44.29 (17.92) 47.86 (20.87) 57.08 (26.12)
BTS-Q — blushing frequency past week
EXP (n= 12) 11.33 (15.59) 5.17 (5.11) 2.42 (2.39) 3.33 (4.50)
TCT (n= 14) 11.92 (8.69) 4.00 (2.99) 4.29 (7.57) 3.92 (5.12)
a N = 9 (EXP)/ N = 12 (TCT) at FU II.
b Means and S.D.s per day, calculated over the past week.
3 The MANOVAs with regard to cheek temperature and skin conductance level revealed no
significant main effect of group [ F hot(2,18) = 0.17, and F hot(2,17) = 0.24, respectively]. The values
at different occasions are summarized in Table 4.
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3.3.6. Clinically significant change and effect sizes
The percentages of patients who demonstrated clinically significant change on
the BTS-Q ‘fear of blushing’ in both treatments are depicted in Table 5. No
differences were found between the two treatments on posttest [c2(1) = 0.1], FU I
[c2(1) = 1.7, P > .1], and FU II [c2(1) = 2.4, P > .1]. Effect sizes, however, were
large at all occasions only for TCT.
For descriptive and informative purposes only, we also included the data from
the other questionnaires that were filled out by patients (see Table 6). Interest-
ingly, the BTS-Q self-reported blushing frequency decreases substantially in both
groups over time.
4. Discussion
The main purposes of the present study were to examine the relative efficacy
of behavioral treatment for fear of blushing above waiting list, and to examine
potential differential treatment effects of EXP and TCT, on fear of blushing,
cognitive change, actual blushing, and self-reported blushing and anxiety. The
major results can be summarized as follows: (1) There was a significant effect of
treatment above waiting with respect to fear of blushing, whereas patients in the
waiting list and treatment condition made equal cognitive improvement; (2) TCT
tended to produce better results with respect to fear of blushing than EXP at
posttest, and at 6-weeks follow-up, TCT produced significantly better cognitive
change than EXP; (3) At 1-year follow-up, treatment effects continued, whereas
differential effects had disappeared; (4) The reduction in fear of blushing was not
paralleled by a reduction in actual blushing during the behavioral assessments.
4.1. Treatment success
Compared to waiting, treatment was significantly more successful in reducing
the blushing phobics’ complaints. Thus, despite the short duration of the
treatment, apparent improvements with regard to fear of blushing could be
demonstrated. Besides, note that our patients’ severity of complaints measured
up with that of clinical subjects (see Bögels & Reith, 1999). Patients with
complaints of this severity usually receive longer treatment than the six sessions,
provided in the present study. Note also that the patients who were assigned to the
waiting-list group seemed to improve somewhat as well, which may have reduced
the sensitivity to detect treatment effects in the present study. This improvement in
the waiting-list group may well be due to waiting-list patients’ optimism with
regard to the forthcoming training. Also, the detailed intake, the keeping of a diary,
the completion of questionnaires, and the behavioral tests, may have served as
exposure assignments and as an attention placebo on the one hand, and have
caused patients to put into perspective the severity of their complaints, on the
other. Taken together, we feel that the significant improvements are promising.
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4.2. TCT versus EXP
At posttest, TCT tended to produce more favorable results with regard to fear
of blushing. The larger effect sizes of TCT in contrast to EXP support this
finding. At FU I, however, differential effects at this variable have disappeared.
This indicates that TCT might act somewhat faster in dispelling fear of blushing
in the short term, but that these initial differences converge in the end. In contrast,
the percentage of clinically significant change is somewhat smaller for TCT than
for EXP. Yet, since patients in the EXP condition started treatment with smaller
pretest scores, it was easier for them to reach the point that was set for clinically
significant change.
At FU I, cognitive change appeared to be significantly greater for TCT. Note
also the descriptive results, suggesting that the credibility of BTS-Q positive
cognitions had increased, especially for TCT. This implies that TCT is somewhat
better in stimulating cognitive change than EXP. By giving patients the oppor-
tunity to experience disconfirming information, through becoming aware of their
objective environment, TCT seems to promote cognitive change. Also, TCT
inhibits patients to rely on their internal sensations rather than on external
information to evaluate how they come across (Clark & Wells, 1995). The
finding that cognitive change during TCT takes place, independent of specific
cognitive restructuring, has an important practical implication; that is, TCT is a
treatment technique that can be acquired by therapists relatively easily, compared
to cognitive therapy (Bögels et al., 1997), which might lead TCT to become the
treatment of choice.
The absence of firm differential effects with respect to fear of blushing might
be due to the fact that both treatment methods bear resemblances to each other.
That is, both treatments imply the use of a hierarchy to practice difficult
situations, and prescribe in-session and between-session exercises in which
exposure to feared situations takes place. Because the EXP was maximalized
regarding the dropping of safety behaviors (Wells et al., 1995), and TCT was set
up to focus attention outward, it might be that patients in both groups were able to
pick up disconfirming information with regard to their dysfunctional schemas
about blushing. Furthermore, inspection of the descriptive data on SFA, directed
at arousal, seems to indicate that this type of attention decreases in both
treatments. Nevertheless, TCT’s tendency to produce better results regarding
fear of blushing is, given the small patient numbers in this study, worth
mentioning. Yet, studies with greater patient numbers are needed to draw firmer
conclusions concerning the relative efficacy of TCT.
4.3. Changes in actual blushing
Treatment did not affect actual blushing during the behavioral tests, neither as
measured physiologically nor as indexed by self-reports. Several explanations
could account for this result. Firstly, the absence of differences between treated
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and nontreated individuals with respect to actual blushing leads us to question the
physiological response pattern of normal control subjects. It would be interesting
to establish whether the physiological responses of nonfearful controls differ
from the physiological responses of patients with fear of blushing. If not, there
would be not much room for improvement with respect to the patients’ blush
responses, after all. Secondly, the two behavioral tests might have been too
distinct from situations in patients’ daily life, making changes in actual blushing
as a result of treatment hard to detect. Thirdly, the absence of differences in actual
blushing between treated patients and waiting-list controls might be due to the
relatively short length of the treatments.
No differential treatment effects in actual blushing could be detected at
posttest. However, since no treatment effects were demonstrated with respect
to actual blushing, at all, it is questionable whether differential effects for type of
treatment could be investigated. Yet, it seems that fear of blushing could be
satisfactorily reduced, independent of a reduction in actual blushing. Moreover,
the significant overall decrease of self-reported blushing at the second behavioral
test (for waiting list and treatment at once), and the substantial decrease in the
BTS-Q ‘blushing frequency’ subscale in both treated groups at posttest, further
supports the notion that actual blushing and subjective blushing are not
necessarily paralleled. Thus, fear of blushing seems to reflect a fearful preoccu-
pation, irrespective of actual facial coloration.
In sum, TCT seems to be an equivalent and potentially more ameliorative
alternative to EXP as a treatment for fear of blushing. The present study shows
some evidence suggesting that TCT has more favorable effects. It remains to be
investigated whether TCT is an effective treatment for social phobics with other
somatic fears (like trembling and sweating), and for social phobics with non-
somatic fears.
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Öst, L. G., Jerremalm, A., & Johansson, J. (1981). Individual response patterns and the effects of
different behavioral methods in the treatment of social phobia. Behaviour Research and Therapy,
19, 1–16.
S. Mulkens et al. / Anxiety Disorders 15 (2001) 413–432 431
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